卫生系统和政策研究

  • 国际标准期刊号: 2254-9137
  • 期刊 h 指数: 12
  • 期刊引用分数: 1.73
  • 期刊影响因子: 1.81
索引于
  • 中国知网(CNKI)
  • 宇宙IF
  • 研究期刊索引目录 (DRJI)
  • OCLC-WorldCat
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • 谷歌学术
  • 夏尔巴罗密欧
分享此页面

抽象的

Current Clinical Approaches to the Treatment of Major Covid-19 Pandemic & the Effectiveness of Immunoboosters and Safety Precautions as Methods of Prevention.

Virmani Mayank, Kaur Mandeep

COVID-19 is declared as a major pandemic with 302,460 deaths and 1,697,934 people have recovered, as of March 13th, 2020. Various clinical trials are being conducted on antiviral drugs- i.e. resemdivir, anti-parasitic drugs-i.e. ivermectin, plasma therapy, and many more. However, there are no accurate or desired outcomes achieved till now. Some drugs pass in-vitro studies and some pass all clinical trials but they also have to lead to Adverse Drug Reactions (ADR’S) or complications. No particular approved treatment or vaccines to treat COVID -19 have been implemented for a full recovery. So, precautionary measures are vital as a method to protect you from this disease that has been showing an increasing number of cases day by day. Natural immune boosters are also helpful as a protective barrier to fight against COVID-19. Social distancing and proper hand hygiene and sanitation are also important safety measures during this pandemic.